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ABSTRACT
Objective: To identify criteria for measuring the eligibility of patients with end-stage
noncancer diseases for palliative care services in Australian residential aged care
facilities.
Methods: No validated set if guidelines were available so five instruments were used: an
adaptation of the American National Hospice Association Guidelines; a recent adaptation
of the Karnofsky Performance Scale; the Modified Barthel Index; the Abbey Pain Score
for assessment of people who are nonverbal and a Verbal Descriptor Scale, also for pain
measurement. In addition, nutritional status and the presence of other problematic
symptoms and their severity were also sought.
Results: The adapted American National Hospice Association Guidelines provided an
initial indicative framework and the other instruments were useful in providing
confirmatory data for service eligibility and delivery.
KEYWORDS: Inclusion criteria, Noncancer disease, Palliative care, Residential aged
care facilities, Terminal care
In the course of conducting a study to investigate
the extent and nature of the provision of pallia-
tive care in residential aged care facilities for
residents with end-stage noncancer diseases, we
realized we lacked adequate criteria for identify-
ing whether these people were nearing the end of
their lives. Although palliative care has been ad-
vocated as a right for every person who is dying
~Field & Addington-Hall, 1999! few palliative care
services have focused on the needs of patients
who die with conditions other than cancer.
The benefits and extension of palliative care be-
yond the limits of cancer have been recognized for
well over two decades ~Saunders, 1978; Wilkes, 1980,
von Gunten & Twaddle, 1996!, and techniques for
physical and emotional palliation learned in the
care of advanced cancer are often relevant to those
with noncancer diagnoses, for example, in the use
of small doses of opioids for severe dyspnea in car-
diac failure or respiratory disease or for the persis-
tent pain of advanced arthritis. Yet in the United
Kingdom, New Zealand, and Australia only 3–16%
of hospice patients have a noncancer diagnosis
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~Health Funding Authority, 1999; National Council
for Hospice and Specialist Palliative Care Service,
2001; Palliative Care Australia, 2003! despite the
fact that the noncancer deaths that could use
palliation are estimated at 50% ~Palliative Care
Australia, 2003!. This percentage is supported by
U.S. figures where 49.5% of patients served by
hospices had a noncancer diagnosis in 2002 and
these figures have shown a dramatic increase from
38% in 2000.
Clearly, patients with noncancer diseases can
benefit from specialist palliative care services, skills,
and hospice philosophy ~Kite et al., 1999!. However,
assessing the palliative care needs of these patients
is dependent on identifying the terminal phase,
which can be problematic ~Luddington et al., 2001!.
A large U.K. national multimethod study on the
management of death and dying in residential and
nursing homes for older people conducted by Sidell
et al. ~1997! found that managers found it difficult
to identify the beginning of the terminal phase of
an illness and tended to make decisions related to
functional demise.
THE NATIONAL HOSPICE
ORGANIZATION GUIDELINES
In an attempt to address the disparity and provide
clinicians and policy makers with some framework
for assessing which patients could be eligible for
hospice services, the American National Hospice
Organization ~NHO; National Hospice Organiza-
tion, 1996! published medical guidelines for deter-
mining prognosis in selected noncancer diseases.
These guidelines specified eligibility criteria for
patients who could be enrolled in hospice services
in the United States and, thus, are markers of
prognosis and specific advanced morbidity. How-
ever, the prime purpose of the NHO guidelines was
to qualify patients for the Medicare Hospice Ben-
efit, which requires a prognosis of 6 months. The
NHO guidelines suggest that patients who have a
Karnofsky Performance Status Scale ~KPS! of 50 or
less and require others to perform at least three of
the six activities of daily living are more likely to
die within the next 6 months. The activities of daily
living used to determine the dependency of an in-
dividual on others and level of impaired functional
status included “bathing, dressing, feeding, trans-
ferring, continence of urine and stool, ~and! ability
to ambulate independently to the bathroom” ~von
Gunten & Twaddle, 1996!.
In assessing Medicare’s proposed hospice eligi-
bility criteria for select noncancer patients it was
found that these criteria would “not have identified
accurately those patients with less than six months
to live upon admission to hospice” ~Schonwetter
et al., 1998!. Lynn ~2001! subsequently adapted the
NHO guidelines, presenting them in two parts:
Part one consisted of three criteria with subgroups
that require the patient to meet all the criteria in
order to be enrolled in a hospice program in the
United States, and are illustrated in Table 1.
Part two highlighted guidelines for specific dis-
eases ranging from blood tests to clinical descrip-
tors. For example, serum levels: creatinine clearance
,0.17ml0s ~10ml0min! and serum creatinine greater
than 707.2 mmol0l ~8.0 mg0dl!. Table 2 shows the
inclusion criteria ~clinical descriptors! for specific
noncancer diseases that require the clinical judg-
ment of health care professionals ~Lynn, 2001!. How-
ever, blood tests to elicit such results are not
routinely conducted in aged care facilities in Aus-
tralia, so further adaptation of these guidelines was
required.
INCLUSION CRITERIA FOR
PARTICIPANTS IN THIS STUDY
Adaptation of Lynn’s (2000) NHO
Guidelines
Following the debates above, members of the re-
search team in our study further adapted the work
of Lynn ~2001! for use in Australian residential
aged care facilities. Table 3 outlines the adapted
inclusion criteria.
Table 1. NHO general guidelines (Lynn, 2001)
The patient should meet all of the following criteria:
1. The patient’s condition is life limiting, and the
resident and0or family know this.
2. The patient and0or family have elected treatment
goals directed toward relief of symptoms, rather
than the underlying disease.
3. The resident has either of the following criteria:
A. Documented clinical progression of the disease,
which may include:
1. Progression of the primary disease process as
listed in the disease-specific criteria, as
documented by physician assessment,
laboratory, radiologic, or other studies;
2. Multiple emergency department visits or
inpatient hospitalizations over the prior 6
months;
3. Nursing assessment may document decline;
4. For residents who do not qualify under 1, 2, or
3, a recent decline in functional status should
be written—clinical judgment is required.
B. Documented recent impaired nutritional status
related to terminal process: unintentional
progressive weight loss of .10% over prior 6
months.
6 Grbich et al.
Other broad criteria for hospice0palliative care
eligibility used to predict prognosis without taking
into account specific diagnoses but including a num-
ber of disparate “clinical indicators which taken
together, are predictive of a short life expectancy on
the order of 6 months or less” ~von Gunten &
Twaddle, 1996, p. 352! can be grouped under two
categories: impaired functional status and impaired
Table 2. NHO specific disease criteria (Lynn, 2001)
Specific diseases Criteria
Heart disease • intractable or frequently recurrent symptomatic heart failure.
• intractable angina pectoris with heart failure.
• optimally treated with diuretics, vasodilators.
Pulmonary disease • severe chronic lung disease, documented by dyspnea at rest, fatigue,
decreased functional ability, or increased exacerbation.
Dementia • unable to ambulate without assistance and unable to communicate
meaningfully.
• medical complications such as: aspiration pneumonia, sepsis,
intractable decubitus ulcers.
• other factors contributing to a poor prognosis include unable to
dress without assistance, unable to bathe properly, incontinence.
Human Immunodeficiency
Virus disease
• life-threatening concomitant conditions.
• other factors contributing to poor prognosis.
• decisions to forgo HIV disease treatment.
Liver disease • advanced cirrhosis with intractable ascites.
• progressive malnutrition and muscle wasting.
Renal disease • end stage renal disease.
• intractable f luid overload.
Acute stroke and coma • evidenced by coma, beyond 3 days duration.
• dysphagia severe enough to prevent the resident from receiving
foods and f luids necessary to sustain life ~no artificial nutrition or
hydration!.
Chronic, after stroke • poor functional status, evidenced by Karnofsky score of ,50%
• medical complications related to debility and progressive clinical
decline such as aspiration pneumonia, upper urinary tract infection,
sepsis.
National Hospice and Palliative Care Organization, General Medical Guidelines for Determining
Prognosis in Selected Noncancer Diseases ~adapted from National Hospice Organization, 1996, up-
dated to ref lect common current practices! ~Reprinted! JAMA February 21, 2001, vol. 285, no. 7, p. 929.
Lynn, J. © 2001 American Medical Association. Reproduced with permission.
Table 3. NHO guidelines (adapted) for Australian residential aged care facilities
Inclusion criteria
A resident is eligible to participate in the study if their primary disease and0or other medical condition
indicates that treatment goals directed toward relief of symptoms are more appropriate than treatment
of the underlying disease and0or medical condition.
A useful way of clarifying whether a resident would be eligible for this palliative care study is to
consider if you would be surprised if the resident died within a few months. If the answer is no, I
wouldn’t be surprised, then the resident could be included in the study.
In addition, the resident should have at least one of the following:
• Multiple admissions to an acute care hospital over the past 6 months where treatment goals have
been palliative not curative.
• Documented continued trajectory of decline in functional status.
• Documented recent impaired nutritional status related to progression of the primary disease or
other medical condition.
• Unanticipated medical crisis which has required that end of life care be discussed.
Adapted with permission from Joanne Lynn, October 6, 2002.
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nutritional status. Those used in this study are
listed below.
Impaired Functional Status—Karnofsky
The Karnofsky Performance Scale ~KPS; Karnof-
sky et al., 1948; Karnofsky & Burchenal, 1949! is
one of the better known prognostication scales in
oncology and has been a method of “quantifying
patients’ status relative to degree of independence
in carrying out normal activities and self care”
~Yates et al., 1980, p. 2220!. Some have consid-
ered the KPS tool to have high predictive capacity
for quantifying the physical functioning of pa-
tients with cancer ~Hutchinson et al., 1979; Grieco
& Long, 1984; Mor et al., 1984; Schag et al., 1984;
Connill et al., 1990; Nikoletti et al., 2000! and in
assisting with prognostication because there is an
association between low KPS scores and short-
ened life expectancy. The tool has 11 levels rang-
ing from normal functioning ~100! to dead ~0!. A
patient with a terminal disease and a KPS score
of 50 or less is deemed to have a limited progno-
sis ~Evans & McCathy, 1985!.
However, there have been problems with the scor-
ing system when using the KPS in the home pallia-
tive care setting ~Nikoletti et al., 2000!. Specifically,
the first problem is the descriptor related to the
location of care. Descriptors for ratings at 20 and 30
in the KPS include assessing the need for hospital-
ization. Philosophically, this descriptor is at odds
with the goal of supporting patients and families in
their wish for a home death ~Nikoletti et al., 2000!.
Indeed, one could argue that residents in aged care
facilities consider this setting their home and their
bed to be the place where they wish to die, thus the
need to provide quality palliative care in the dom-
iciliary setting is unequivocal. In addition, Niko-
letti et al. ~2000, p. 301! state: “the second concern
is that the KPS scores in advanced cancer popula-
tions tend to cluster at the low end of the scale,
indicating the need for more sensitive descriptors
that ref lect clinically significant changes in physi-
cal function.” David Thorne developed the Thorne
KPS ~TKPS; unpublished but delineated in Niko-
letti et al., 2000, and tested in a pilot study against
the KPS for use in the home hospice setting by
Kristjanson et al., 1998!. It specifically does not
assess the location of care, nor the need for hospi-
talization, and modifies the descriptors in the mid-
dle and lower levels of the scale. The usefulness of
the KPS and the TKPS was evaluated by Nikoletti
et al. ~2000!, who suggested that although agree-
ment was only 47%, the TKPS identified a larger
proportion of home hospice patients at lower levels
of function and may be a more sensitive indicator of
performance at these levels, which would be a dis-
tinct advantage for palliative care populations.
The middle range of scores in the TKPS refers
to professional visits that the patient may need
either less ~B 60! or more than once a week ~B 50;
see Table 4!. These particular functional status
indicators are neither relevant nor useful for
patients in hospitals or in aged care facilities
~Woods, 2001!. Moreover, in relation to the TKPS
functional assessment tool, Woods ~2001, p. 2!
states, “the measure does not appear to ref lect
perceived need for services rather than perceived
functional status—professional visits may be re-
quired frequently for symptom control reasons or
interventions not related to functional status, e.g.,
frequent dressing changes in patients able to carry
on normal activity.” In addition, Woods reports
that, in order to develop a functional status score
that would be suitable to be used in both in-
patient and domiciliary settings, modification of
both the KPS and TKPS was necessary. He devel-
oped a new functional status assessment tool
known as the WARP Karnofsky WKPS ~illus-
trated below!. The emboldened areas in Table 4
represent scale definitions discarded in the devel-
opment of the WKPS ~Woods, 2001!.
Impaired Functional Status—Barthel
Index
The Barthel Index ~BI!measures performance based
on the degree of assistance required by an individ-
ual to perform 10 items of mobility and self-care,
including dressing, eating, elimination, hygiene, mo-
bility, working, and shopping. Validity and reliabil-
ity of the Barthel Index have been established ~van
der Putten et al., 1999!. In palliative care, Bennett
and Ryall ~2000, p. 158! noted that “in patients in
hospice the rate of change in physical functioning
was a more useful indicator of survival then abso-
lute measures.” In our study, we utilized the 10-
item modified Barthel Index ~McDowell & Newell,
1986! in the initial and final assessment of partici-
pants, spanning a 10-week period.
Impaired Nutritional Status
Impaired nutritional status has predictable conse-
quences. An increased probability of death corre-
lates with patients who demonstrate more than
10% weight loss over a previous 6-month period
that is unplanned and progressive ~NHO, 1996; von
Gunten & Twaddle, 1996!. Also, a broad correlation
can be drawn with impaired performance status in
patients. In other words, there is a strong likelihood
that impairment of nutritional and performance
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status exists in patients who have advanced non-
cancer diseases.
Pain Scale: The Abbey Pain Scale
This is a 1-min numerical indicator of pain status
developed for people with end-stage dementia and
limited verbalization in residential aged care facil-
ities who require palliative care ~validated in Abbey
et al., 2004!. Vocalizations, facial expressions, body
language, and behavioral, physiological, and phys-
ical changes are monitored and rated to give an
overall score.
Pain Scale: Verbal Descriptor Scale
(VDS)
This instrument was developed to assess pain in
cancer patients and its reliability has been indi-
cated ~Grossman et al., 1992!. Patients’ rate their
pain on a 6-point scale ranging from no pain to
mild, discomforting, distressing, horrible, or excru-
ciating pain.
Aim, sampling, and method
The study wherein these inclusion criteria were
used, aimed to describe the demographic and clin-
ical profiles of residents with noncancer diagnoses
who die in aged care facilities in urban and rural
South Australia, to assess the palliative care needs
of these residents, to examine the current contribu-
tion and demand for palliative care services to aged
care facilities, and to provide strategies to address
unmet needs.
Amultimethod two-stage approach utilizing quan-
titative and qualitativemethodswas used. In Stage 1
a representative sample of the 298 residential aged
Table 4. Comparative Karnofsky performance scales
Score
Original Karnofsky
~KPS!
Thorne modified Karnofsky
~TKPS!
Woods modified Karnofsky
~WKPS!
~A!100 Normal; no complaints; no
evidence of disease.
Normal; no complaints; no
evidence of disease.
Normal; no complaints; no
evidence of disease.
~A! 90 Able to carry on normal
activity; minor signs or
symptoms.
Able to carry on normal
activity; minor signs or
symptoms.
Able to carry on normal
activity; minor signs or
symptoms.
~A! 80 Normal activity with effort;
Some signs or symptoms of
disease.
Normal activity with effort;
Some signs or symptoms of
disease.
Normal activity with effort;
Some signs or symptoms of
disease.
~B! 70 Cares for self; unable to
carry on normal activity or
do active work.
Cares for self; unable to
carry on normal activity or
do active work.
Cares for self; unable to
carry on normal activity or
do active work.
~B! 60 Requires occasional
assistance but is able to
care or most of their needs.
Requires professional
visits less than once a
week.
Requires occasional
assistance but is able to
care or most of their needs.
~B! 50 Requires considerable
assistance, frequent
medical care.
Requires professional
visits more than once a
week.
Requires considerable
assistance and frequent
medical care.
~C! 40 Disabled; requires
special care and
assistance.
In bed more than 50% of
the time.
In bed more than 50% of
the time.
~C! 30 Severely disabled;
hospitalization
necessary;
active supportive
treatment is necessary.
Almost completely bedfast. Almost completely bedfast.
~C! 20 Very sick;
hospitalisation
necessary; active
supportive treatment is
necessary.
Totally bedfast and
requiring extensive nursing
care by professionals
and0or family.
Totally bedfast and
requiring extensive nursing
care by professionals
and0or family.
~C! 10 Moribund, fatal
processes progressing
rapidly.
Comatose or barely
rousable.
Comatose or barely
rousable.
0 Dead Dead Dead
Service identification, noncancer patients 9
care facilities in South Australia were surveyed to
quantify the extent of specialist palliative care in-
volvement, provide information on resident death
rates, and to estimate the current need for pallia-
tive care for thosewith noncancer diagnoses. In Stage
2 a random sampling of metropolitan and rural fa-
cilities identified 23 in whom there were partici-
pants with noncancer disease who were considered,
using the NHO’s adapted guidelines and following
discussion with registered nurses in each residen-
tial aged care facility, to be nearing the end of life,
and from these, 69 residents agreed to participate
~see Fig. 1!.
Details regarding the palliative care needs and
services required for residents with a noncancer di-
agnosis were collected prospectively over a 10-week
period at each metropolitan and rural site. A com-
prehensive initial assessment was conducted on each
participant using the WARP Modified Karnofsky
Score, the Modified Barthel Index, the Abbey Pain
Score, and the Verbal Descriptor Scale. Case notes
and staff interviews enabled nutrition and symp-
tom assessment. Subsequently, four assessments
were conducted on a fortnightly basis, and a final
assessment was completed at the end of 10 weeks.
RESULTS
The adapted NHO guidelines provided a general
tool for the researchers and staff in aged care facil-
ities to identify more precisely residents with non-
cancer diagnoses who were considered to be nearing
the end of life.
Woods-Modified Karnofsky Performance
Score
The mean initial WKPSs for all residents were well
under the 50 indicated by the NHO guidelines. The
initial score was 32.6 and the final score 10 weeks
later was 31.6. There were no significant differ-
ences between the initial and final scores ~t 0.806,
df  68, p  0.423!. However, there was a trend
toward a decrease in WKPS from initial to final
assessment. Figure 2 compares the mean initial
and final WKPS scores for residents who did not die
and those who did. There was no statistically sig-
nificant difference between the initial scores for
residents who did and did not die ~27.5 and 34.2; t
1.743, df  67, p  0.86!. However there was a
statistically significant difference between the mean
final WPKS for residents who did not die and those
who did ~35.3 and 19.4; t4.0, df 67, p 0.00!,
indicating a decline in functional ability toward the
end of life in residents who died.
Modified Barthel Index (10-Item)
The maximum score of the Index is 20, which indi-
cates ability to complete activities of daily living
with minimal or no assistance. The initial Barthel
score in the study was 3.1 and the final was 2.9,
indicating a very low level of mobility and self-care
capacity. There were no significant differences be-
tween the initial and final scores. Figure 3 indi-
cates the initial and final Barthel scores for residents
who died and those who did not. For residents who
did not die, initial and final scores were equivalent
~t  0.463, df  67, p  0.645!. However, for resi-
dents who died, there was a decline in the Barthel
Score, indicating greater dependence, but this dif-
ference was not statistically significant ~t  0.56,
df  67, p  0.577!.
Nutrition
Forty-four ~64%! residents were on a limited diet
~vitamized or soft food! at initial and final assess-
ment. Nine ~13%! residents had no oral intake in
Fig. 1. Geographical distribution of the sample of residents from
aged care facilities ~n  69! in Adelaide and rural and regional
centers of South Australia.
Fig. 2. Initial and final WKPS scores of residents ~n  69!.
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the final assessment, compared with three ~4%! at
the beginning of the study ~Fig. 4!.
Pain and Other Symptoms
When the above measurements are matched with
information from case notes, the two pain scales,
and interviews with clinical staff in the residential
aged care facilities, there were a number of symp-
toms that would have benefited from specialist
palliative input. The symptoms experienced by res-
idents during the study were rated by the research-
ers into three degrees of severity, namely, mild,
moderate, and severe, and recorded at each collec-
tion point. Mild indicated that there was an issue
and it was managed well, sometimes by nonphar-
macological means, and was generally resolved.
Moderate indicated that there was an issue that
was managed with a moderate degree of success, by
using regular or prn ~pro re nata; as the situation
demands!medications in combination or separately,
but the issue was an ongoing concern and required
ongoing intervention~s!. Severe indicated that there
was an issue that was not controlled, regardless of
interventions tried.
Figure 5 shows the most common symptoms that
were rated moderate or severe as weakness0fatigue
~49%!, restlessness ~42%!, anxiety ~42%!, anorexia
~38%!, constipation ~34%!, oral discomfort ~33%!,
and dysphagia ~30%!. While pain had been listed as
present for 69% of residents only 16% of residents
had pain that was moderate or severe.
These results are similar to those of Cartwright
~1991!, who identified symptoms of both cancer and
noncancer palliative patients. Pain, anorexia, in-
somnia, incontinence, and confusion were present
Fig. 3. Initial and final modified Barthel Index scores by resident death.
Fig. 4. Nutritional status ~initial and final assessments!.
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in both populations, but were less prevalent for
those with noncancer diseases, whereas dyspnea,
anxiety, and constipation were much the same.
In the current study, symptoms, recorded in or-
der of prevalence, were constipation ~75%!, pain
~71%!, dysphagia ~57%!, weakness ~55%!, dyspnea
~32%!, and depression ~29%!. Prevalence of symp-
toms does not indicate severity or indicate effective-
ness of management techniques.
DISCUSSION
This study is the first in Australia to attempt to
quantify whether resident deaths were related to a
cancer or noncancer diagnosis. In Stage 1, four out
of five deaths reported were related to a noncancer
diagnosis. In Stage 2, only residents with a noncan-
cer diagnosis were included and therefore all deaths
were related to noncancer diagnoses. The multiple
comorbidities of those 16 residents who died in-
cluded 13 ~81%!with haematological0cardiovascular
disorders, 11 ~69%! with dementia, six ~38%! with
pulmonary conditions, and four ~25%! with neuro-
logical disorders. These figures are ref lective of the
national trend, where cardiovascular disease is the
main cause of death for both males and females
aged 85 years and older ~Australian Institute of
Health and Welfare, 2002!. The overwhelming pro-
portion of deaths with a noncancer diagnosis in this
setting has important implications for palliative
care service provision of support to residential aged
care facilities.
This article reports on criteria used in order to
identify patients in a study of residents in aged care
facilities with end-stage noncancer diagnoses who
should be considered for palliative services. Eligi-
bility criteria for palliative care services, be they a
palliative care approach, specialist palliative care,
and0or palliative interventions, is an important topic
within the broader palliative care debates. The in-
clusion guidelines developed comprised a combina-
tion of specially modified NHO guidelines together
with the WARP Karnofsky Performance Scale, the
10-item modified Barthel index, two pain scales—
one verbal and nonverbal—plus an assessment of
nutritional status and identification of other prob-
Fig. 5. Symptoms rated moderate or severe.
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lematic symptoms. Together these provided a use-
ful and accurate approach to identifying patients
with a noncancer diagnosis who should be consid-
ered for palliative services. The adapted NHO guide-
lines provided a general framework within which
other tests could produce confirmatory data. Over
the 10 weeks of data collection, results were consis-
tent. The WKPS indicated that all 69 patients had
a score well under the 50 required by the NHO
guidelines ~average 32!; the Barthel Index indi-
cated that patients averaged a low level of 3020 for
mobility and self-care. Nutrition information was
equally indicative with 64% of the group being on
vitamized or soft food with increasing numbers on
nil orally. Although the results regarding pain and
other symptoms could equally apply to patients
who were not nearing the end of life, this informa-
tion provided useful insights as to where symptoms
were severe, where clinical staffs were having dif-
ficulties with management, and where palliative
interventions would have been appropriate. The
limitation of this study was the time frame of 10
weeks in terms of data collection, during which only
16 of the 69 patients died—a longer time frame may
have produced results that were more statistically
relevant, but the minimum variation in results be-
tween initial and final assessments of those who
did and did not die clarified that the adapted guide-
lines worked well as a primary indicator.
This study has broad implications for service
delivery to meet the needs of the increasing num-
bers of older people who will die from noncancer
diagnoses. Given the principle that all people have
a right to receive appropriate care and to die with
dignity, it can be argued that the use of the adapted
NHO guidelines together with pain scales and close
monitoring provide a strategy for enabling the pro-
vision of appropriate end-of-life care for these pa-
tients and their families. Clarifying appropriate
eligibility0inclusion criteria for people with noncan-
cer diagnoses is a crucial step within the broader
debates about palliative care approaches and spe-
cialist palliative care services. This article contrib-
utes to these critical debates.
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